Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: April 2011
-
April 27, 2011 – 27th Annual Joint Patent Practice Seminar (Connecticut, New Jersey, New York, and Philadelphia Intellectual Property Law Associations) – New York, NY April 29, 2011 – Ethics in the Practice of Intellectual Property Law (John Marshall Law School Center for Intellectual Property Law) – Chicago, IL April 27-29, 2011 – Patent Strategies…
-
By Kevin E. Noonan — The House of Representatives Committee on the Judiciary today approved H.R. 1249 (the "America Invents Act") and reported the bill to the House floor by a vote of 32-3, with Representatives John Conyers, Jr. (D-MI), Steve King (R-IA), and James Sensenbrenner, Jr. (R-WI) voting against the measure. Along the way,…
-
By James DeGiulio — Cordis Stent Found to Infringe Boston Scientific Patent Boston Scientific Corp. secured a favorable ruling on summary judgment in its patent infringement suit against Cordis Corp. over one of its drug-eluting stents. In 2003, Boston Scientific sued Cordis in the U.S. District Court for the District of Delaware for infringement of…
-
By Donald Zuhn — On Tuesday, House Judiciary Committee Chairman Lamar Smith (R-TX) offered a Manager's Amendment to H.R. 1249, the House version of the America Invents Act (see "House Judiciary Chairman Releases Manager's Amendment to H.R. 1249"). While response to the amended version of H.R. 1249 appears to be more muted than that for…
-
By Kevin E. Noonan — If politics is the art of the possible, House Judiciary Committee Chairman Lamar Smith (R-TX) (at right) is doing whatever he can to make passage of H.R. 1249 (the "America Invents Act," aka the House patent reform bill) into law. That includes release today of a Manager's Amendment, which makes…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Alcon Pharmaceuticals Ltd et al. v. Watson Laboratories Inc. et al.1:11-cv-00293; filed April 7, 2011 in the District Court of Delaware • Plaintiffs: Alcon Pharmaceuticals Ltd; Alcon Research Ltd.• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals…
-
By Donald Zuhn — On March 31, the U.S. Patent and Trademark Office announced that it was implementing a new e-Petitions system and that eight different petitions would initially be made available through the system. The e-Petitions system automates the petitions process so that applicants can input the requisite data into a secure web interface…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Eli Lilly and Company v. Accord Healthcare, Inc.1:11-cv-00261; filed April 4, 2011 in the District Court of North Carolina Infringement of U.S. Patent No. 5,919,485 ("Oral 2-Methyl-thieno-benzodiazepine Formulation," issued July 6, 1999) following a Paragraph…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office announced that it would begin accepting requests for prioritized examination of patent applications on May 4, 2011. The program was initially announced as part of the Enhanced Examination Timing Control Initiative (or Three Track program) last June (see "USPTO Publishes Notice Regarding Enhanced…
-
By James DeGiulio — Last year, following Genzyme's inability to supply patient needs for the enzyme replacement drug Fabrazyme, concerned Fabry patients petitioned the Department for Health and Human Services (HHS) to exercise the government's "march-in" rights under the Bayh-Dole Act and force Genzyme to license the patents covering the drug to other manufacturers who…
Patent Docs 